HIPAA and Pharma: Covered Entity vs. Business Associate Explained

HIPAA Covered Entities Defined

Who qualifies as a covered entity

Under HIPAA, covered entities are the organizations directly subject to the Privacy, Security, and Breach Notification Rules. They include health plans, health care clearinghouses, and health care providers that conduct standard electronic transactions, such as claims, eligibility inquiries, and payment remittance.

• Health plans: insurers, HMOs, government programs, and many self-insured employer group health plans.
• Health care clearinghouses: entities that translate nonstandard health data to standard formats and vice versa.
• Providers: hospitals, clinics, physicians, pharmacies, and others—but only if they transmit protected health information in standard electronic transactions.

Protected health information in scope

Protected health information (PHI) is individually identifiable health information held or transmitted by a covered entity or its business associate, in any form. Electronic PHI (ePHI) is PHI in digital form and triggers the Security Rule’s administrative, physical, and technical security safeguards.

Why electronic transactions matter

Many providers become covered entities because they send or receive PHI using standard electronic transactions. If a provider never conducts such transactions, it may not be a HIPAA covered entity, even though it delivers health care.

Role of Pharmaceutical Companies Under HIPAA

Pharmaceutical manufacturers are not usually HIPAA covered entities because they do not operate health plans, clearinghouses, or bill for care using standard electronic transactions. However, they frequently interact with PHI and can become business associates when working on behalf of covered entities.

Common pharma scenarios

• Patient support and hub services (benefits investigations, prior authorization support, nurse educator outreach) that access PHI for a provider or health plan.
• Risk Evaluation and Mitigation Strategies (REMS), safety surveillance, and adverse event intake that handle PHI for a covered entity.
• Specialty pharmacy distribution partnerships where manufacturers receive limited PHI to coordinate access or adherence programs.

Clinical trials data and research

In research, sponsors often receive de-identified data or a limited data set under a data use agreement. Simply receiving clinical trials data does not automatically make a manufacturer a business associate. If the sponsor performs services for a covered entity that involve PHI (beyond research disclosures authorized or waived), a business associate relationship may arise.

Direct-to-consumer programs

When you collect health information directly from consumers—for example, through mobile apps, registries, or websites—those data may fall outside HIPAA if no covered entity or business associate role exists. Other laws, including state privacy and consumer protection laws, can still apply.

Business Associate Responsibilities in Pharma

When a pharmaceutical company acts as a business associate, it must comply with specific HIPAA requirements and the terms of its business associate agreement.

Core responsibilities

• Use and disclose PHI only as permitted by the business associate agreement or as required by law, and apply the minimum necessary standard.
• Implement security safeguards for ePHI: risk analysis, risk management, access controls, encryption where appropriate, audit logs, and incident response.
• Train workforce members with access to PHI and enforce sanctions for violations.
• Flow down obligations to subcontractors that create, receive, maintain, or transmit PHI on your behalf.
• Maintain documentation, including policies, procedures, and risk assessments, and retain them for the required period.

Breach handling and individual rights support

• Assess incidents to determine whether they constitute a breach and promptly notify the covered entity per the breach notification requirements in your agreement.
• Support covered entities in meeting HIPAA rights, including access to PHI, amendment requests, and accounting of disclosures, when your systems hold the relevant data.

Requirements for Business Associate Agreements

A well-drafted business associate agreement (BAA) clarifies permissible PHI uses and embeds operational controls. You should ensure each BAA covers the following elements.

Essential BAA terms

• Permitted and required uses and disclosures of PHI, expressly limiting marketing, sales, or analytics beyond the agreed scope.
• Security safeguards for ePHI, including risk management, access controls, and encryption expectations.
• Breach notification requirements: timelines, required content, cooperation duties, and forensic support.
• Minimum necessary and de-identification standards, including handling of clinical trials data and any limited data sets under data use agreements.
• Subcontractor management: written agreements imposing the same restrictions and safeguards.
• Support for individual rights: access, amendment, and accounting of disclosures when data reside with the business associate.
• Term, termination rights for material breach, and return or destruction of PHI at contract end where feasible.
• Right of the covered entity to audit or receive attestations, and a duty to make practices and records available to regulators.

Direct Liability of Business Associates

The HITECH Act and subsequent rules make business associates directly liable for certain HIPAA violations, independent of any covered entity’s actions. Liability is not limited to contract breach; it includes regulatory enforcement and penalties.

Direct violations that trigger enforcement

• Impermissible uses or disclosures of PHI, including failures to apply minimum necessary.
• Failure to implement required Security Rule safeguards for ePHI.
• Failure to provide breach notification to the covered entity without unreasonable delay.
• Failure to enter into compliant agreements with subcontractors handling PHI.
• Failure to provide access to ePHI, or to disclose information to regulators when required.

Civil monetary penalties can apply to business associates, and egregious, knowing violations may carry criminal exposure. Strong governance and documented risk management are essential.

Compliance and Enforcement Procedures

HIPAA is enforced primarily by the Office for Civil Rights (OCR). You should prepare for investigations triggered by complaints, reported breaches, or audits, and resolve issues through corrective action plans where needed.

Operational playbook

• Maintain a current risk analysis, policies, and training records; test incident response plans regularly.
• Use intake and triage procedures to identify security incidents quickly and evaluate breach risk.
• Document every decision path—containment steps, risk assessments, notifications, and remediation.
• Coordinate closely with covered entities to meet timing, content, and media obligations for breach notifications.
• Continuously monitor vendors and subcontractors for compliance and security performance.

Impact of State Laws on HIPAA Compliance

HIPAA sets a federal floor. If a state law is more protective of privacy or grants greater individual access, it generally controls. You must map obligations across states, especially when programs collect data directly from consumers.

Key implications

• State breach notification statutes often impose additional or faster timelines and specific content requirements.
• Consumer privacy laws may cover health-related data outside HIPAA contexts, such as app-based programs and loyalty initiatives.
• Specialized laws—like genetic, biometric, or mental health confidentiality statutes—can further restrict sharing of clinical trials data or patient support files.

Conclusion

For pharma, the dividing line is function. You are rarely a covered entity, but you become a business associate when you perform services for a provider or health plan that involve PHI. Robust BAAs, disciplined security safeguards, and clear breach notification requirements—grounded in HIPAA and informed by the HITECH Act and state law—are the foundation of sustainable compliance.

FAQs

Are pharmaceutical companies usually covered entities under HIPAA?

No. Manufacturers typically are not covered entities because they do not operate health plans, clearinghouses, or bill for care via standard electronic transactions. Pharmacies are usually covered providers, but manufacturers themselves are generally not.

When do pharmaceutical companies act as business associates under HIPAA?

They act as business associates when performing services for a covered entity that involve PHI—such as patient support programs, REMS activities, safety surveillance, or specialty therapy coordination—subject to a business associate agreement.

What are the requirements for business associate agreements in the pharmaceutical industry?

BAAs must define permitted uses and disclosures, mandate Security Rule safeguards for ePHI, set breach notification requirements, require minimum necessary, flow down obligations to subcontractors, support individual rights, permit oversight, and address termination and PHI return or destruction.

How are business associates held liable for HIPAA violations?

Under the HITECH Act, business associates are directly liable for impermissible uses or disclosures, inadequate security safeguards, failure to notify of breaches, lack of subcontractor agreements, and failures to provide access or cooperate with regulators—exposing them to civil penalties and, for willful misconduct, potential criminal liability.